Research
AI Revolutionizes Biologic Drug Discovery
MIT Technology Review AIhigh confidence
Why it matters
- →AI reduces drug discovery timelines and costs, making new treatments more accessible.
- →It enables targeting of previously untreatable diseases, expanding therapeutic possibilities.
- →Integration with robotics and automation enhances efficiency and scale in drug development.
AI is playing a crucial role in revolutionizing biologic drug discovery, as highlighted by AstraZeneca's efforts to integrate AI into their R&D processes. By using AI to prioritize and design drug candidates, AstraZeneca is able to focus on the most promising molecules, reducing development timelines and costs. The company's 'lab of the future' in Cambridge, Massachusetts, combines AI with robotic automation to create a continuous discovery system. This approach not only speeds up the development process but also enables the exploration of new drug classes and targets previously considered untreatable.
Read original
